Johnson Pharmacare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | TBA | TBA | TBA |
| Operating Expense | 0.04 | TBA | TBA |
| Net Profit | -0.04 | TBA | TBA |
| Net Profit Margin | TBA | TBA | TBA |
| Earning Per Share | TBA | TBA | TBA |
| EBIDTA | -0.04 | TBA | TBA |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | TBA |
| Operating Expense | 0.04 |
| Net Profit | -0.04 |
| Net Profit Margin | TBA |
| Earning Per Share | TBA |
| EBIDTA | -0.04 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 2.53 | 3.26 | 0.76 |
| Operating Expenses Annual | 3.86 | 3.13 | 0.76 |
| Operating Profit Annual | -1.33 | 0.13 | 0.00 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -1.29 | 0.10 | 0.00 |
| Tax Annual | -0.04 | 0.04 | 0.00 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 2.53 |
| Operating Expenses Annual | 3.86 |
| Operating Profit Annual | -1.33 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | -1.29 |
| Tax Annual | -0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.04 | 0.23 | 0.28 |
| Cash Flow from Operations | -0.40 | 4.90 | -0.11 |
| Cash Flow from Investing | -0.94 | -5.01 | TBA |
| Cash Flow from Financing | 1.30 | -0.08 | 0.06 |
| Cash Flow at the End | TBA | 0.04 | 0.23 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.04 |
| Cash Flow from Operations | -0.40 |
| Cash Flow from Investing | -0.94 |
| Cash Flow from Financing | 1.30 |
| Cash Flow at the End | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 8.70 | 3.99 | TBA |
| PBIT Margin (%) | 8.70 | 3.99 | TBA |
| PBT Margin (%) | 8.70 | 3.99 | TBA |
| Net PROFIT Margin (%) | -50.99 | 3.07 | TBA |
| Return On Networth / Equity (%) | TBA | 0.17 | TBA |
| Return On Networth /Employed (%) | TBA | 0.24 | TBA |
| Return On Assets (%) | -2.04 | 0.18 | TBA |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.04 | 0.06 | 0.01 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 8.70 |
| PBIT Margin (%) | 8.70 |
| PBT Margin (%) | 8.70 |
| Net PROFIT Margin (%) | -50.99 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -2.04 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 0.00 | 1.09 | 5.60 |
| Non Current Assets Annual | 59.83 | 58.89 | 53.88 |
| Total Shareholders Funds Annual | 56.95 | 58.24 | 58.14 |
| Total Assets Annual | 59.83 | 59.98 | 59.48 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 0.00 |
| Non Current Assets Annual | 59.83 |
| Total Shareholders Funds Annual | 56.95 |
| Total Assets Annual | 59.83 |
No Data Availabe
